BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte

  Astra and Incyte are pushing forward on the development of immunotherapy combination treatments.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson’s Gene Therapy Program

  Shares of Voyager have fallen more than 12 percent in premarket trading after Sanofi Genzyme walked away from its $845M gene therapy treatment for Parkinson’s disease.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Grail CSO Exits to Join Bay Area VC Firm Foresite Capital

  Vikram Bajaj joined Grail only a year ago.

  October 31, 2017

   · 

  1 min read
• 

  Lone Star Bio

  Houston Medtech Firm Corinnova Scores $6.1M

  Corinnova’s CEO says the company has developed a device called EpicHeart to tackle heart failure.

  October 31, 2017

   · 

  1 min read
• BioMidwest

  Grand River Aseptic Manufacturing Sponsoring Grand Rapids .1K to End Duchenne

  Proceeds from the 100-meter race on Nov. 4 will be donated to Parent Project Muscular Dystrophy (PPMD), the largest U.S. nonprofit organization focused on ending Duchenne muscular dystrophy.

  October 31, 2017

   · 

  1 min read
• 

  Business

  Lundbeck Names Interim Leader, Effective Nov. 1, 2017

  Anders Gotzsche will serve as interim CEO while the company looks for a replacement for Kare Schultz who leaves the company Oct. 31 for the CEO position at Teva.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  X-Spine Systems to Shut Down, Lays Off 54 Employees

  X-Spine is shutting down its Ohio facility and terminating the employees between December and February 2018.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• Novo Nordisk A/S: Share Repurchase Programme - Oct. 13, 2017

  This programme is part of the overall share repurchase programme of up to DKK 16 billion to be executed during a 12-month period beginning 2 February 2017.

  October 31, 2017

   · 

  2 min read
• Drug Development

  Agile Therapeutics Presents Additional Phase III SECURE Trial Results for Twirla at the ASRM Scientific Congress Expo 2017

  Agile Therapeutics today announced additional data from its Phase III SECURE trial of Twirla which showed women experienced mean decreases in length of bleeding and spotting episodes.

  October 31, 2017

   · 

  6 min read
• Policy

  Agilis Biotherapeutics Announces Orphan Product Designation Approval in Europe for the Treatment of Friedreich Ataxia

  The EC’s approval follows a positive opinion in July 2017 from the European Medicine Agency’s (EMA) Committee for Orphan Medicinal Products (COMP).

  October 31, 2017

   · 

  5 min read